DE3886999T3 - Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung. - Google Patents

Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung.

Info

Publication number
DE3886999T3
DE3886999T3 DE3886999T DE3886999T DE3886999T3 DE 3886999 T3 DE3886999 T3 DE 3886999T3 DE 3886999 T DE3886999 T DE 3886999T DE 3886999 T DE3886999 T DE 3886999T DE 3886999 T3 DE3886999 T3 DE 3886999T3
Authority
DE
Germany
Prior art keywords
disease virus
virus vaccine
newcastle disease
newcastle
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3886999T
Other languages
English (en)
Other versions
DE3886999T2 (de
DE3886999D1 (de
Inventor
Zichria Zakay Rones
Reuven Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26321682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3886999(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL82586A external-priority patent/IL82586A0/xx
Priority claimed from IL85266A external-priority patent/IL85266A0/xx
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of DE3886999D1 publication Critical patent/DE3886999D1/de
Publication of DE3886999T2 publication Critical patent/DE3886999T2/de
Application granted granted Critical
Publication of DE3886999T3 publication Critical patent/DE3886999T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3886999T 1987-05-19 1988-05-19 Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung. Expired - Fee Related DE3886999T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL82586A IL82586A0 (en) 1987-05-19 1987-05-19 Newcastle disease virus(ndv)vaccine and method for the application thereof
IL85266A IL85266A0 (en) 1988-01-29 1988-01-29 Newcastle disease virus(ndv)vaccine and method for the application thereof

Publications (3)

Publication Number Publication Date
DE3886999D1 DE3886999D1 (de) 1994-02-24
DE3886999T2 DE3886999T2 (de) 1994-04-28
DE3886999T3 true DE3886999T3 (de) 2001-06-13

Family

ID=26321682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3886999T Expired - Fee Related DE3886999T3 (de) 1987-05-19 1988-05-19 Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung.

Country Status (8)

Country Link
US (1) US5152981A (de)
EP (1) EP0292293B2 (de)
JP (1) JPS63307828A (de)
AU (1) AU607997B2 (de)
CA (1) CA1335959C (de)
DE (1) DE3886999T3 (de)
ES (1) ES2061647T3 (de)
NZ (1) NZ224567A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
HU203983B (en) * 1988-12-05 1991-11-28 Mta Allatorvostudomanyi Kutato Process for producing living vaccine against fowlpox
WO1994025627A1 (en) * 1993-04-30 1994-11-10 Lorence Robert M Methods of treating and detecting cancer using viruses
DE69632235T2 (de) * 1995-10-18 2004-08-26 Akzo Nobel N.V. Newcastle-Krankheitsvirus-Kombinationsimpfstoff
AUPO389796A0 (en) 1996-11-29 1996-12-19 Techsearch Incorporated Filter with counter flow clearing
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US20030044384A1 (en) 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
HUP0302278A3 (en) 1999-04-15 2011-01-28 Pro Virus Treatment of neoplasms with viruses
US20110110975A1 (en) * 2009-11-06 2011-05-12 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
KR101258619B1 (ko) * 2010-07-12 2013-04-29 대한민국 새로운 약독형 유전아형의 뉴캣슬병 바이러스 백신주 및 이를 포함하는 뉴캣슬병 바이러스 백신
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
CN103937817B (zh) * 2014-02-17 2016-04-13 北京华都诗华生物制品有限公司 鸡新城疫病毒yt毒株、其全基因组序列及其应用
TWI603740B (zh) * 2016-06-30 2017-11-01 Avian Newcastle disease vaccine adjuvant and its preparation method
CN107296868A (zh) * 2017-08-29 2017-10-27 王学艳 一种防治鸡新城疫的中药组合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection

Also Published As

Publication number Publication date
NZ224567A (en) 1990-08-28
JPS63307828A (ja) 1988-12-15
CA1335959C (en) 1995-06-20
DE3886999T2 (de) 1994-04-28
EP0292293A2 (de) 1988-11-23
ES2061647T3 (es) 1994-12-16
EP0292293A3 (en) 1990-01-24
DE3886999D1 (de) 1994-02-24
EP0292293B2 (de) 2001-02-07
EP0292293B1 (de) 1994-01-12
US5152981A (en) 1992-10-06
AU607997B2 (en) 1991-03-21
AU1631188A (en) 1988-11-24

Similar Documents

Publication Publication Date Title
DE3886999T3 (de) Newcastle-krankheitsvirus-Impfstoff und Methode für seine Verwendung.
EP0149040A3 (en) Modified live pseudorabies viruses, vaccines for pseudorabies disease containing same, methods for production of same and methods for use of same
DE3787613D1 (de) Qualitative immunochromatographische methode und vorrichtung.
DE69034134D1 (de) Methode zum sammeln von vaginalen absonderungen
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DE3881469T2 (de) Tonerwärmefixierwalze und Verfahren zur Herstellung.
DE3873791D1 (de) Maschine und methode zur bodenvorbereitung.
DE3781569T2 (de) Mittel zur oralen verwendung.
DE3750176D1 (de) Impfstoff und verfahren zur herstellung.
DE68917324D1 (de) Methode zur Immobilisierung von physiologisch aktiven Substanzen.
ES2018092B3 (es) Sabana quirurgica y metodo para su fabricacion.
DE3683987D1 (de) Methode zur reinigung von alkoxysilanen.
NL192456B (nl) Humane eiwitten.
DE69002606D1 (de) Methode zur waermebehandlung von laktoferrin ohne seine physiologische aktivitaet zu verlieren.
DE3780981T2 (de) Fluoridglas und seine verwendung.
DE69022707D1 (de) Methode zur Fluordecarboxylierung.
DE3764041D1 (de) Verfahren zur herstellung von (4-hydroxyphenyl-) 4-hydroxy-benzoat und seine verwendung.
DE3486291D1 (de) Verfahren zur Blutabnahme.
ATE99956T1 (de) Newcastle-krankheitsvirus-impfstoff und methode fuer seine verwendung.
DE3786870T2 (de) Methode zur Herstellung von Proteinen.
DE3786511T2 (de) Immobilisiertes Enzympräparat und seine Verwendung.
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
DE69702890T2 (de) Methode zur Vorbereitung und Reinigung von 1,1,1.-Tris(4-hydroxyphenyl)ethan
DE3882842T2 (de) Methode zur Herstellung von Cineolen.
DE3885713T2 (de) Synchrotronstrahlungsquelle und Methode für ihre Herstellung.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8339 Ceased/non-payment of the annual fee